GSEA (gene set enrichment analysis) further demonstrated marked involvement of tyrosine/tryptophan metabolism (showing substantial enrichment in the GM group compared with WM) and neuroactive ligand–receptor interactions in both WT and Gpr35−/− PD models (Fig. S3A to C). This evidence concerns the gene GPR35 and Parkinson disease.